Table 2 Pathologic staging of patients with clinically localised plasmacytoid carcinoma treated with neoadjuvant chemotherapy or surgery first.

From: Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma

 

Neoadjuvant

Surgery first

p value

 

(N = 33)

(N = 29)

Pathologic T stage

 <pT2

7 (21)

2 (7)

0.048

 pT2–4

26 (79)

27 (93)

 

Pathologic N stage

 Node negative

19 (58)

18 (62)

0.018

 Node positive

7 (21)

11 (38)

 

 Not available

7 (21)

0 (0)

 

AJCC staging

 0–I

7 (21)

2 (7)

0.155

 II–IV

26 (79)

27 (93)

 
  1. Values represent frequency (percentage).
  2. AJCC American Joint Committee on Cancer.